advertisement

Topcon

Xing W 9

Showing records 1 to 9 | Display all abstracts from Xing W

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Quartilho A
Eye 2016; 30: 602-607
65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Vickerstaff V
Trials 2015; 16: 517
66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Simkiss P
Eye 2016; 30: 602-607
65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Ambler G; Bunce C
Trials 2015; 16: 517
66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Zekite A
Eye 2016; 30: 602-607
65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Xing W
Trials 2015; 16: 517
66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Xing W; Wormald R
Eye 2016; 30: 602-607
65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Gazzard G;
Trials 2015; 16: 517
66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Bunce C
Eye 2016; 30: 602-607

Issue 17-3

Change Issue


advertisement

Oculus